Itamar™ Medical Announces Third Quarter Preliminary Revenue Results and Reinstates Revenue Guidance for Full Year 2020GlobeNewsWire • 10/13/20
Itamar Medical’s WatchPAT™300 Home Sleep Apnea Testing Device Receives Approval in JapanGlobeNewsWire • 10/01/20
The German Sleep Society (DGSM) Recognizes PAT™ based Technology in its New Sleep-Related Breathing Disorders Guidelines, Further Benefitting Itamar Medical’s Approach to Sleep Apnea DiagnosisGlobeNewsWire • 09/21/20
Itamar Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020GlobeNewsWire • 09/03/20
Prior Authorization Requirement for Itamar’s WatchPAT™ Home Sleep Apnea Test Removed for all Independence Blue Cross MembersGlobeNewsWire • 08/31/20
Itamar Medical Ltd. (ITMR) CEO Gilad Glick on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/12/20
Itamar Medical to Report Second Quarter Financial Results and Host Conference Call on Tuesday, August 11, 2020GlobeNewsWire • 07/27/20
Itamar Medical Ltd. Sponsored ADR (ITMR) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 06/22/20
Itamar Medical Receives CE Mark Approval for its WatchPAT™ ONE, the First Fully Disposable Home Sleep Apnea TestGlobeNewsWire • 05/04/20
Itamar™ Medical Funds Clinical Study to Evaluate Potential Impact of CPAP Therapy to Patients with COVID-19 GlobeNewsWire • 04/22/20
Itamar™ Medical Announces First Quarter 2020 Preliminary Revenue Increase of Approximately 40%GlobeNewsWire • 04/13/20
Itamar™ Medical and BetterNight to Join Forces Offering Referred Patients Home Based Virtual-Care Sleep Solution for the Diagnosis and Treatment of Sleep ApneaGlobeNewsWire • 04/06/20
Itamar™ Medical Implements Broad Range of Actions in Response to COVID-19 PandemicGlobeNewsWire • 03/20/20
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial IntelligenceGlobeNewsWire • 03/02/20
Itamar™ Medical Announces Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT™ Device in Diagnosing Sleep ApneaGlobeNewsWire • 02/18/20
Itamar™ Medical Announces Closing of Upsized Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSsGlobeNewsWire • 02/04/20
Itamar™ Medical Announces Upsizing and Pricing of Public Offering of American Depositary SharesGlobeNewsWire • 01/31/20
Itamar™ Medical Announces Proposed $30 Million Offering of American Depositary SharesGlobeNewsWire • 01/28/20
Itamar™ Medical Announces Preliminary Revenue for Fourth Quarter and Full Year 2019 and Revenue Guidance for Full Year 2020GlobeNewsWire • 01/13/20
Itamar Medical Selected to Participate in the Prestigious Weizmann Institute Project 10KGlobeNewsWire • 01/09/20